System Transmission

Top Signal

100#1 JOB

Activity

2169Ripe

+925 today

System

Livenow

Terminal Asset View

stockNASDAQ

SCNI

$0.71-2.68%

Scinai Immunotherapeutics Ltd

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

20Overripe

Live Analysis Active

Company Mission

Scinai Immunotherapeutics develops antibody-based treatments for serious diseases like autoimmune disorders and cancer. Their therapies work by targeting specific proteins in the body to help the immune system fight disease. The company makes money through partnerships with larger pharmaceutical companies, licensing their technology, and potentially selling successful treatments once approved.

SCN

Industry Context

The biotechnology industry focuses on developing medical treatments using biological systems. Companies in this space often have high research costs and long development timelines, but successful treatments can generate significant revenue. Investors watch clinical trial results closely as they can dramatically impact stock prices.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

67Matrix

Market Momentum

38.8— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.3x— Normal Volume

Today's Change

-2.68%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing SCNI across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:41 AM UTC

As-of 03-15-2026 07:25 UTC

Develops antibody treatments for autoimmune diseases and makes money by licensing its drug candidates to larger pharmaceutical companies.

Weekly chart shows price coiling in a tight range near recent lows, suggesting a potential breakout move is building.

Biotech sector showing volatility as investors rotate into defensive healthcare plays, benefiting companies with late-stage clinical programs, suggesting clinical programs.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...